| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJPHAR.2010.09.085 |
| P8608 | Fatcat ID | release_43t435vcanfrnn467tmbnp2ftq |
| P698 | PubMed publication ID | 21034734 |
| P50 | author | Dina M Abo-Elmatty | Q82231680 |
| P2093 | author name string | Yasser M Moustafa | |
| Asmaa Radwan | |||
| El-Sayed E El-Awady | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 335-341 | |
| P577 | publication date | 2010-10-29 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies | |
| P478 | volume | 650 |
| Q47109333 | Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats |
| Q35980880 | Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. |
| Q38975452 | An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures |
| Q55075057 | Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives. |
| Q89473012 | Antioxidant and cardioprotective effects of Ilex cornuta on myocardial ischemia injury |
| Q99632123 | Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity |
| Q46359474 | Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways |
| Q37316669 | Assessment of the antitumor potential of Bithionol in vivo using a xenograft model of ovarian cancer |
| Q28482418 | Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts |
| Q58787859 | Cabbage () Protects against HO-Induced Oxidative Stress by Preventing Mitochondrial Dysfunction in H9c2 Cardiomyoblasts |
| Q52677836 | Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers. |
| Q90536542 | Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity |
| Q33645678 | Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments |
| Q38555776 | Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies |
| Q64063805 | Chronic amoxicillin exposure affects : assessment of hematological, ionic compounds, biochemical, and enzymological activities |
| Q52553038 | Cisplatin and cisplatin analogues perfusion through isolated rat heart: the effects of acute application on oxidative stress biomarkers. |
| Q44624084 | Cisplatin binding and inactivation of mitochondrial glutamate oxaloacetate transaminase in cisplatin-induced rat nephrotoxicity |
| Q38194125 | Cisplatin induced paroxysmal supraventricular tachycardia. |
| Q47774211 | Comparative Investigation of Protective Effects of Metyrosine and Metoprolol Against Ketamine Cardiotoxicity in Rats |
| Q49597512 | Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis |
| Q64119825 | D-Methionine Ameliorates Cisplatin-Induced Muscle Atrophy via Inhibition of Muscle Degradation Pathway |
| Q39541239 | Development of highly effective three-component cytoprotective adjuncts for cisplatin cancer treatment: synthesis and in vivo evaluation in S180-bearing mice |
| Q42646273 | Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation |
| Q37671456 | Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy |
| Q43209942 | Effect of disulfiram on ketamine-induced cardiotoxicity in rats |
| Q92498512 | Effect of ethyl acetate extract of usnea longissima on esophagogastric adenocarcinoma in rats1 |
| Q33749642 | Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes. |
| Q39774754 | Effects of thymoquinone against cisplatin-induced cardiac injury in rats. |
| Q92131748 | Evaluating the protective potency of Acacia hydaspica R. Parker on histological and biochemical changes induced by Cisplatin in the cardiac tissue of rats |
| Q38341299 | Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review |
| Q36249363 | Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines. |
| Q55071881 | Hypertension in malignancy-an underappreciated problem. |
| Q38934713 | Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics |
| Q48230329 | Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain. |
| Q97887520 | Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment |
| Q64245417 | Physiopathology and diagnosis of cardiotoxicity in patients submitted to chemotherapy treatment |
| Q42700981 | Prophylactic and Therapeutic Potential of Acetyl-L-carnitine against Acetaminophen-Induced Hepatotoxicity in Mice |
| Q42527938 | Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice |
| Q28079909 | Protective effect of silymarin against chemical-induced cardiotoxicity |
| Q55018308 | Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model. |
| Q42664998 | Risk of coronary artery disease is not linked to head and neck cancers: a population-based retrospective cohort study |
| Q35791807 | Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart |
| Q26770933 | Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives |
| Q36109004 | Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines |
| Q46662849 | Synthesis and biological evaluation of hydroxyl-substituted Schiff-bases containing ferrocenyl moieties. |
| Q46533109 | Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses |
| Q42378419 | The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy |
| Q41680108 | The effects of N-acetylcysteine on cisplatin-induced cardiotoxicity on isolated rat hearts after short-term global ischemia |
| Q54397973 | The protective effect of thiamine pyrophosphate, but not thiamine, against cardiotoxicity induced with cisplatin in rats. |
| Q85083661 | The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats |
| Q37626273 | The role of antioxidants in the era of cardio‑oncology |
| Q91791565 | Thyroid hormone protects cardiomyocytes from H2O2-induced oxidative stress via the PI3K-AKT signaling pathway |
| Q26766269 | Vascular Complications of Cancer Chemotherapy |
| Q28543359 | Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells |
Search more.